CONMED (NYSE:CNMD) Lowered to “Hold” Rating by StockNews.com
StockNews.com lowered shares of CONMED (NYSE:CNMD – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday. Other equities analysts also recently issued reports about the stock. Wells Fargo & Company cut their price target on shares of CONMED from $70.00 to $57.00 and set an “equal […]
